ENST00000432782.2:n.1098T>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000432782.2(PLCE1-AS2):​n.1098T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.382 in 151,982 control chromosomes in the GnomAD database, including 12,244 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.38 ( 12244 hom., cov: 31)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

PLCE1-AS2
ENST00000432782.2 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.278

Publications

8 publications found
Variant links:
Genes affected
PLCE1-AS2 (HGNC:51206): (PLCE1 antisense RNA 2)
PLCE1 (HGNC:17175): (phospholipase C epsilon 1) This gene encodes a phospholipase enzyme that catalyzes the hydrolysis of phosphatidylinositol-4,5-bisphosphate to generate two second messengers: inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG). These second messengers subsequently regulate various processes affecting cell growth, differentiation, and gene expression. This enzyme is regulated by small monomeric GTPases of the Ras and Rho families and by heterotrimeric G proteins. In addition to its phospholipase C catalytic activity, this enzyme has an N-terminal domain with guanine nucleotide exchange (GEF) activity. Mutations in this gene cause early-onset nephrotic syndrome; characterized by proteinuria, edema, and diffuse mesangial sclerosis or focal and segmental glomerulosclerosis. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Sep 2009]
PLCE1 Gene-Disease associations (from GenCC):
  • nephrotic syndrome, type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.531 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000432782.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLCE1
NM_016341.4
MANE Select
c.1207-32002A>G
intron
N/ANP_057425.3
PLCE1-AS2
NR_120615.1
n.1097T>C
non_coding_transcript_exon
Exon 3 of 3
PLCE1
NM_001288989.2
c.1207-32002A>G
intron
N/ANP_001275918.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLCE1-AS2
ENST00000432782.2
TSL:1
n.1098T>C
non_coding_transcript_exon
Exon 3 of 3
PLCE1
ENST00000371380.8
TSL:1 MANE Select
c.1207-32002A>G
intron
N/AENSP00000360431.2
PLCE1
ENST00000371375.2
TSL:1
c.282+10796A>G
intron
N/AENSP00000360426.1

Frequencies

GnomAD3 genomes
AF:
0.382
AC:
58024
AN:
151864
Hom.:
12211
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.536
Gnomad AMI
AF:
0.265
Gnomad AMR
AF:
0.448
Gnomad ASJ
AF:
0.378
Gnomad EAS
AF:
0.549
Gnomad SAS
AF:
0.293
Gnomad FIN
AF:
0.245
Gnomad MID
AF:
0.481
Gnomad NFE
AF:
0.289
Gnomad OTH
AF:
0.418
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
4
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
2
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
4
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.382
AC:
58101
AN:
151982
Hom.:
12244
Cov.:
31
AF XY:
0.381
AC XY:
28334
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.537
AC:
22221
AN:
41408
American (AMR)
AF:
0.449
AC:
6865
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.378
AC:
1312
AN:
3470
East Asian (EAS)
AF:
0.548
AC:
2825
AN:
5154
South Asian (SAS)
AF:
0.292
AC:
1405
AN:
4816
European-Finnish (FIN)
AF:
0.245
AC:
2595
AN:
10592
Middle Eastern (MID)
AF:
0.469
AC:
137
AN:
292
European-Non Finnish (NFE)
AF:
0.289
AC:
19627
AN:
67954
Other (OTH)
AF:
0.415
AC:
873
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1714
3429
5143
6858
8572
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
532
1064
1596
2128
2660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.326
Hom.:
19243
Bravo
AF:
0.409
Asia WGS
AF:
0.403
AC:
1400
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.74
DANN
Benign
0.49
PhyloP100
-0.28
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4918082; hg19: chr10-95859929; API